Results 71 to 80 of about 33,732 (139)

Remdesivir in COVID-19: A Focus on Pediatric Cardiac Patients. [PDF]

Can J Infect Dis Med Microbiol
Bsat D, Safi D, Arabi M.
europepmc   +1 more source

Remdesivir in COVID-19: pros and cons. [PDF]

Front Pharmacol
Rouhana El Feghali Y, Rabih L, Abdul Khalek J, Arabi M.   +3 more
europepmc   +1 more source

Time-varying characteristics of remdesivir-treated patients hospitalised due to COVID-19: an electronic health record study. [PDF]

J Glob Health
Hoe JK, Blond K, Jimenez-Solem E, Berry M, Chiang M, Ankarfeldt MZ, Petersen J.   +6 more
europepmc   +1 more source

Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study

Journal of Comparative Effectiveness Research
Aim: This observational study investigated the association between remdesivir treatment during hospitalization for COVID-19 and 30-day COVID-19-related and all-cause readmission across different variants time periods.
Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Andre C Kalil, Vishnudas Sarda, Celine Der-Torossian, Thomas Oppelt, Mark Berry, Alpesh N Amin   +9 more
doaj   +1 more source

Evaluation of artificial intelligence identified ipratropium bromide for the treatment of coronavirus disease 2019. [PDF]

Sci Rep
Jung DS, Cheon S, Kim CM, Seo JW, Sung SJ, Kim DY, Lee JH, Kim W, Kang J, Yun NR, Kim YR, Kim DM.   +11 more
europepmc   +1 more source

Dynamical Fragment Molecular Orbital Interaction Analysis of SARS-CoV‑2 RNA-Dependent RNA Polymerase and Remdesivir. [PDF]

ACS Omega
Miyakawa S, Okuwaki K, Kawashima Y, Handa Y, Furuishi T, Yonemochi E, Kato K, Fukuzawa K.   +7 more
europepmc   +1 more source

Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database. [PDF]

Ther Adv Drug Saf
Xiong X, Chen Z, Yan B.
europepmc   +1 more source

Remdesivir may exacerbate ischemic acute kidney injury through molecular alterations in PGC-1α and apoptosis pathways: An in vivo study. [PDF]

PLoS One
Bagheri Y, Malekinejad Z, Hejazian SM, Abdollahpour A, Khajepour F, Farahbod M, Ahmadi S, Matin S, Zununi Vahed S.   +8 more
europepmc   +1 more source

Remdesivir safety and clinical outcomes in pediatric COVID-19: a retrospective study. [PDF]

BMC Infect Dis
Barati L, Lashkarbolouk N, Ghorbani S, Shahkar L.   +3 more
europepmc   +1 more source

Remdesivir as a potent antiviral against prototype and current epidemic Oropouche virus strains (BeAn19991 and PE-IAM4637). [PDF]

Virus Res
Yoshikawa R, Ishii Y, Sano N, Yasuda J.
europepmc   +1 more source